Abstract
Objective To evaluate the clinical performance of digital rectal examination (DRE) and machine learning-assisted impedance spectroscopy (ONIRY) for detecting obstetric anal sphincter injuries (OASI) compared to three-dimensional endoanal ultrasound (EAUS).
Design A post-hoc analysis of data from a prospective, comparative, multicentre, international study (NCT04903977).
Setting Poland, Czech Republic, Slovakia, and Spain.
Population 152 vaginally delivered women to 8 weeks post-partum.
Methods Participants were divided into two groups based on EAUS results: Group I (no OASI, including 1st and 2nd degree perineal tears per OASIS classification) and Group II (OASI, including 3rd and 4th-degree tears per OASIS classification). DRE and impedance measurements using the ONIRY system were performed. The machine learning (ML) model for ONIRY was trained and validated. The diagnostic outcomes of ONIRY and DRE were compared to EAUS.
Main Outcome Measures Accuracy, sensitivity, and specificity.
Results DRE’s performance versus EAUS was 67.8% for accuracy, 44.3% for sensitivity, and 83.5% for specificity. After completion of ML model training, impedance spectroscopy’s accuracy, sensitivity, and specificity were 87.0%, 90.6%, and 84.6%, respectively, compared with EAUS.
Conclusion DRE is insufficient for OASI detection. The ML-assisted impedance spectroscopy demonstrated higher accuracy and could facilitate rapid OASI detection post-delivery.
Funding The study was financed by the European Union’s Fast Track program through the Polish National Centre for Research and Development (POIR.01.01.01-00-0726/18)
Competing Interest Statement
K.B. is a founder and management board member at OASIS Diagnostics, the author of the related patent and R&D strategy, an independent consultant, and a Takeda trainer. M.M., M.R., K.K., and P.I. are staff of OASIS Diagnostics. A.S. is an independent Ethicon, Takeda, Pfizer, and Sofar consultant. H.H. and P.J. received remuneration as study investigators. S.S., R.DT., A.S., H.H., C.R., S.A., DE.A.R., A.St., J.B., R.Fr., M.G., A.D., and R.F. are independent consultants and OASIS Diagnostics' Scientific Advisory Board members.
Funding Statement
The study was financed by the European Union as part of the Fast Track program, conducted in Poland by the Polish National Centre for Research and Development (POIR.01.01.01-00-0726/18).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study received approval from the ethics committees of the respective study sites on the following dates: 19 March 2021 by the Ethics Committee of the Institute for Maternal and Child Care (approval no. 1/19.03.2021), 27 April 2021 by the Ethics Committee for Research with Medicines of the Health Areas of Leon and Bierzo (approval no. 2186), 9 June 2021 by the Ethics Committee of the University Hospital of Brno (approval no. 47/21Zdrav.), 14 October 2021 by the Ethics Committee at the Regional Medical Chamber in Warsaw (approval no. KB/1362/21), and 25 July 2022 by the Ethics Committee at AGEL Hospital Kosice-Saca (approval no. ONIRY 3/2/2020).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data underlying this paper are not publicly available as they constitute the intellectual property of the company.
